Press Releases

Date	Title	Company
05-Jan-2022	Neurointerventional Devices Market to Expand at a Healthy CAGR of 8% through 2031	MARKITWIRED Latest Market Reports
05-Jan-2022	Bioprocess Technology Market will Reach Revenues Worth US$ 78.8 Billion by 2031	MARKITWIRED Latest Market Reports
05-Jan-2022	Sterile Compounding Pharmacies Market is Expected to Witness Healthy Growth at 7.2% CAGR through 2031	MARKITWIRED Latest Market Reports
05-Jan-2022	Patient Lateral Transfer Devices Market is Expected to Witness Healthy Growth at 6% CAGR through 2031	MARKITWIRED Latest Market Reports
05-Jan-2022	Medical Case Management Service Market Globally Expected to Drive Growth through 2031	MARKITWIRED Latest Market Reports
05-Jan-2022	Medical Device Coating Market to Expand at a Healthy CAGR of 7.2% through 2031	MARKITWIRED Latest Market Reports
05-Jan-2022	OTC Herbal and Traditional Medicines Market to Expand at a Healthy CAGR of 4% through 2031	MARKITWIRED Latest Market Reports
05-Jan-2022	Chemotherapy-Induced Nausea and Vomiting (CINV) Treatment Market to Expand at a Healthy CAGR of 6% through 2031	MARKITWIRED Latest Market Reports
05-Jan-2022	BIOCAPTIVA Provides Update and Remains on Track to Transform the Liquid Biopsy Market for Cancer Management	BIOCAPTIVA
05-Jan-2022	Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines from AstraZeneca	Covis Pharma Group
05-Jan-2022	OXURION to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference	OXURION
05-Jan-2022	Genmab and Synaffix Enter into License Agreement for ADC Technology	Genmab
05-Jan-2022	Thrombolytic Science Granted a Second US Patent on Its Clot Dissolving Therapy, A Novel, Nature-inspired Treatment for Ischemic Strokes	Thrombolytic Science, LLC
05-Jan-2022	Hansa Biopharma enters into agreement with AskBio to evaluate feasibility of imlifidase as pre-treatment ahead of gene therapy in Pompe disease	Hansa Biopharma
05-Jan-2022	AlzeCure presents novel Alzstatin data at the 11th Pharmaceutical Profiling meeting	AlzeCure
05-Jan-2022	ProQR Announces Last Patient Has Completed 12 Month Visit in Phase 2/3 Illuminate Trial of Sepofarsen	ProQR Therapeutics N.V.
05-Jan-2022	ICR responds to NICE decision not to recommend olaparib for advanced prostate cancer	The Institute of Cancer Research
05-Jan-2022	Calibre Scientific Acquires AmpliTech, a French Distributor of Reagents and Instruments Specializing in Molecular Pathology, Cytogenetics, and Molecular Genetics	Calibre Scientific
05-Jan-2022	Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare Diseases in the Greater China Region	Santhera
05-Jan-2022	Novo Holdings participates in EUR 110 million first closing of Sound Bioventures Fund I	Novo Holdings